Britannia Life Sciences Inc. (CSE:BLAB)
0.0600
0.00 (0.00%)
Jun 3, 2025, 1:22 PM EDT
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Nov '20 Nov 30, 2020 | Nov '19 Nov 30, 2019 | 2016 - 2018 |
Laboratory Testing | 4.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Laboratory Testing Growth | 21.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Safety and Other Compliance | 3.17M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Safety and Other Compliance Growth | 8.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Management Fees | 189.77K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Management Fees Growth | 5.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Manufacturing and Packaging | 182.75K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Online | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Online Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Distribution and Partnerships | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Business to Business | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Nov '20 Nov 30, 2020 | Nov '19 Nov 30, 2019 | 2016 - 2018 |
Canada | 7.57M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Canada Growth | 18.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|